Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by moonball32on Aug 22, 2023 5:12pm
271 Views
Post# 35600688

Trading

TradingSo it would appear that the permanent codes were not granted,  which should not be a surprise to anyone.  Rob needs to quit hyping these products and be realistic.  The investment community knows he is full of it, as they say his eyes are brown for a reason. All other products in this medical realm are selling on temp codes, it's time for him to find distributors with reputable and reliable sales teams and stop the blabbering and start selling.  DME was-is a flop, no sales in 2 yrs, time to cut them loose if he hasn't already. 
The company desperately needs revenue and it's time for Rob to put on his big boy pants and get to work selling this product vs taking about selling it. The pattern of disappointments just keeps on going, when will it ever stop !
<< Previous
Bullboard Posts
Next >>